164 related articles for article (PubMed ID: 29278517)
21. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
22. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
23. Familial Hypercholesterolemia (FH) Registry Worldwide: A Systematic Review.
Amerizadeh A; Javanmard SH; Sarrafzadegan N; Vaseghi G
Curr Probl Cardiol; 2022 Oct; 47(10):100999. PubMed ID: 34571102
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
[TBL] [Abstract][Full Text] [Related]
25. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.
; Wilemon KA; Patel J; Aguilar-Salinas C; Ahmed CD; Alkhnifsawi M; Almahmeed W; Alonso R; Al-Rasadi K; Badimon L; Bernal LM; Bogsrud MP; Braun LT; Brunham L; Catapano AL; Cillíková K; Corral P; Cuevas R; Defesche JC; Descamps OS; de Ferranti S; Eiselé JL; Elikir G; Folco E; Freiberger T; Fuggetta F; Gaspar IM; Gesztes ÁG; Grošelj U; Hamilton-Craig I; Hanauer-Mader G; Harada-Shiba M; Hastings G; Hovingh GK; Izar MC; Jamison A; Karlsson GN; Kayikçioglu M; Koob S; Koseki M; Lane S; Lima-Martinez MM; López G; Martinez TL; Marais D; Marion L; Mata P; Maurina I; Maxwell D; Mehta R; Mensah GA; Miserez AR; Neely D; Nicholls SJ; Nohara A; Nordestgaard BG; Ose L; Pallidis A; Pang J; Payne J; Peterson AL; Popescu MP; Puri R; Ray KK; Reda A; Sampietro T; Santos RD; Schalkers I; Schreier L; Shapiro MD; Sijbrands E; Soffer D; Stefanutti C; Stoll M; Sy RG; Tamayo ML; Tilney MK; Tokgözoglu L; Tomlinson B; Vallejo-Vaz AJ; Vazquez-Cárdenas A; de Luca PV; Wald DS; Watts GF; Wenger NK; Wolf M; Wood D; Zegerius A; Gaziano TA; Gidding SS
JAMA Cardiol; 2020 Feb; 5(2):217-229. PubMed ID: 31895433
[TBL] [Abstract][Full Text] [Related]
26. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
27. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
[TBL] [Abstract][Full Text] [Related]
28. Cascade screening for familial hypercholesterolemia should be organized at a national level.
Leren TP; Bogsrud MP
Curr Opin Lipidol; 2022 Aug; 33(4):231-236. PubMed ID: 35942821
[TBL] [Abstract][Full Text] [Related]
29. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
[TBL] [Abstract][Full Text] [Related]
31. CaRe high - Cascade screening and registry for high cholesterol in Germany.
Schmidt N; Grammer T; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Laufs U; Otte B; Steinhagen-Thiessen E; Wanner C; März W
Atheroscler Suppl; 2017 Nov; 30():72-76. PubMed ID: 29096864
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia.
Hovland A; Mundal LJ; Igland J; Veierød MB; Holven KB; Bogsrud MP; Tell GS; Leren TP; Retterstøl K
Atherosclerosis; 2017 Nov; 266():69-73. PubMed ID: 28992466
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in genetic testing for familial hypercholesterolemia.
Iacocca MA; Hegele RA
Expert Rev Mol Diagn; 2017 Jul; 17(7):641-651. PubMed ID: 28524730
[TBL] [Abstract][Full Text] [Related]
34. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE
J Clin Lipidol; 2011; 5(3):133-140. PubMed ID: 21600517
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.
Mundal L; Igland J; Ose L; Holven KB; Veierød MB; Leren TP; Retterstøl K
Eur J Prev Cardiol; 2017 Jan; 24(2):137-144. PubMed ID: 27794106
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study.
Toleikyte I; Retterstøl K; Leren TP; Iversen PO
Circulation; 2011 Oct; 124(15):1606-14. PubMed ID: 21911783
[TBL] [Abstract][Full Text] [Related]
37. Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration.
Bellgard MI; Walker CE; Napier KR; Lamont L; Hunter AA; Render L; Radochonski M; Pang J; Pedrotti A; Sullivan DR; Kostner K; Bishop W; George PM; O'Brien RC; Clifton PM; Bockxmeer FMV; Nicholls SJ; Hamilton-Craig I; Dawkins HJ; Watts GF
J Atheroscler Thromb; 2017 Oct; 24(10):1075-1084. PubMed ID: 28344196
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
Mundal L; Retterstøl K
Curr Opin Lipidol; 2016 Aug; 27(4):388-97. PubMed ID: 27070076
[TBL] [Abstract][Full Text] [Related]
39. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
40. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
Saltijeral A; Pérez de Isla L; Alonso R; Muñiz O; Díaz-Díaz JL; Fuentes F; Mata N; de Andrés R; Díaz-Soto G; Pastor J; Pinilla JM; Zambón D; Pinto X; Badimón L; Mata P;
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):444-450. PubMed ID: 27913073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
